切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2017, Vol. 11 ›› Issue (04) : 326 -329. doi: 10.3877/cma.j.issn.1674-1358.2017.04.003

临床论著

抗病毒药物治疗对带状疱疹患者血清细胞因子IL-1β、IL-6、IL-18和TNF-α的影响
沈秉正1, 高翔2, 吴杰3, 吴玥3, 祝成亮4, 喻研5,()   
  1. 1. 430060 武汉市,武汉大学人民医院药学部;430072 武汉市,病毒学国家重点实验室
    2. 430060 武汉市,武汉大学人民医院中心实验室
    3. 430060 武汉市,武汉大学人民医院药学部
    4. 430072 武汉市,病毒学国家重点实验室;430060 武汉市,武汉大学人民医院检验科
    5. 430030 武汉市,华中科技大学同济医学院附属同济医院消化内科
  • 收稿日期:2016-09-11 出版日期:2017-08-15
  • 通信作者: 喻研
  • 基金资助:
    病毒学国家重点实验室开放研究基金资助项目(No. 2016KF002); 湖北省自然科学基金青年项目(No. 2015CFB350)

Effects of antiviral drug therapy on serum IL-1β, IL-6, IL-18 and TNF-α in patients with herpes zoster

Bingzheng Shen1, Xiang Gao2, Jie Wu3, Yue Wu3, Chengliang Zhu4, Yan Yu5,()   

  1. 1. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China; State Key Laboratory of Virology, Wuhan 430072, China
    2. Central Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China
    3. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China
    4. State Key Laboratory of Virology, Wuhan 430072, China; Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China
    5. Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 43030, China
  • Received:2016-09-11 Published:2017-08-15
  • Corresponding author: Yan Yu
引用本文:

沈秉正, 高翔, 吴杰, 吴玥, 祝成亮, 喻研. 抗病毒药物治疗对带状疱疹患者血清细胞因子IL-1β、IL-6、IL-18和TNF-α的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2017, 11(04): 326-329.

Bingzheng Shen, Xiang Gao, Jie Wu, Yue Wu, Chengliang Zhu, Yan Yu. Effects of antiviral drug therapy on serum IL-1β, IL-6, IL-18 and TNF-α in patients with herpes zoster[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2017, 11(04): 326-329.

目的

探究带状疱疹患者行抗病毒药物治疗前后血清细胞因子白细胞介素-1β(IL -1β)、IL-6、IL-18和肿瘤坏死因子-α(TNF-α)水平的变化。

方法

筛选出符合纳入标准的带状疱疹患者共18例,分别于使用抗病毒药物前和治疗7 d后检测血清中细胞因子IL-1β、IL-6、IL-18和TNF-α含量。

结果

患者经过抗病毒药物治疗后,18例患者血清中IL-1β(t = 18.46)、IL-6(t = 6.15)、IL-18(t = 21.50)和TNF-α(t = 10.95)水平较用药前显著降低,差异均具有统计学意义(P均< 0.001)。但其中3例患者血清中细胞因子IL-6水平较用药前反而有所升高;2例患者血清中细胞因子TNF-α水平较用药前并无显著变化。治愈1个月后随访发现,抗病毒药物治疗后IL-6水平较高的1例患者出现明显神经疼痛,另1例患者治愈后偶感神经痛,未经处理症状均自行缓解;治愈后,血清IL-6和TNF-α水平均较高的1例患者中出现带状疱疹后遗神经痛。

结论

经过抗病毒药物治疗,患者炎症状态均得到改善,但少数IL-6和TNF-α持续高水平的患者可能出现带状疱疹后遗神经痛。

Objective

To investigate the changes of the serum cytokines levels of interleukin (IL)-1β, IL-6, IL-18 and tumor necrosis factor-α (TNF-α) in patients with herpes zoster before and after the treatment of antiviral medication.

Methods

According to the inclusion criteria, total of 18 patients with herpes zoster in our hospital were selected. The levels of serum cytokines IL-1β, IL-6, IL-18 and TNF-α were detected before and after the treatment of antiviral drug therapy, respectively.

Results

After the treatment, the statistical results showed the levels of serum cytokines IL-1β (t = 18.46), IL-6 (t = 6.15), IL-18 (t = 21.50) and TNF-α (t = 10.95) of the 18 patients significantly decreased (all P < 0.001). The levels of serum cytokine IL-6 of 3 cases increased compared with the levels before treatment. The levels of serum cytokine TNF-α of 2 cases displayed no significantly change after treatment. Follow-up visits after one month, the patient with high level of IL-6 after the treatment of antiviral drug therapy felt neuropathic pain, which the symptom remit without any treatment. But one patient with high level of both IL-6 and TNF-α emerged post-herpetic neuralgia.

Conclusions

After the treatment of antiviral medication, the inflammatory condition had improved in all patients. But the status of sustained high levels of serum IL-6 and TNF-α may lead post-herpetic neuralgia.

表1 18例患者的基本情况及治疗前后血清中4种细胞因子水平(ng/L)
表2 18例患者抗病毒治疗前后血清中4种细胞因子水平( ± s,ng/L)
[1]
傅伟. 更昔洛韦治疗带状疱疹的疗效观察[J]. 中国民族民间医药,2010,19(20):126.
[2]
Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia[J]. Pain,2000,87(2):121-129.
[3]
张学军主编. 皮肤性病学[M]. 北京: 人民卫生出版社,2008:63-64.
[4]
钟敏, 曾因明, 柳垂亮, 等. 脊髓TNF-α, IL-1β和IL-6在神经病理性疼痛过程中的表达变化[J]. 中国疼痛医学杂志,2010,16(1):42-44.
[5]
Ohfu M, Masuzaki M, Inoue S, et al. Interleukin-6 in the cerebrospinal fluid of two patients with herpes zoster meningitis[J]. No To Hattatsu, 2001,33(3):270-275.
[6]
Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation[J]. Neurobiol Dis,1998,5(4):209-227.
[7]
陈大伟, 谢鹏, 邹德智, 等. 带状疱疹后遗神经痛患者血清IL-6水平与神经损伤的关系[J]. 中国神经免疫学和神经病学杂志,2005,12(3):140-142.
[8]
徐晓巍, 王金忠. 干扰素联合更昔洛韦治疗带状疱疹的临床疗效及对患者后遗神经痛及IL-6, IL-10的影响研究[J]. 中国生化药物杂志,2015,35(11):55-57.
[9]
张璇, 张玉萍, 郭智. IL-18的研究进展[J]. 实用癌症杂志,2012,27(5):533-535.
[10]
Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells[J]. Nature,1995,378(6552):88-91.
[11]
Dnarello CA. IL-18: a TH1-inducing, pro-inflammatory cytokine and new member of the IL-1 family[J]. J Allergy Clin Immunol,1999,103(1):11-24.
[12]
郭斌杰, 陈德宇. 带状疱疹后遗神经痛与白介素和TNF-α的关系[J]. 西南军医,2012,14(1):115-116.
[13]
Amsler L, Malouli D, DeFilippis V. The inflammasome as a target of modulation by DNA viruses[J]. Future Virol, 2013,8(4):357-370.
[14]
赵延峰, 杨彦忠, 崔澂. 白细胞介素18的研究进展[J]. 医学综述,2010,16(21):3205-3209.
[15]
Ferreira J, Marques HH, Ferriani MPL, et al. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study[J]. Lupus,2016,25(7):754-759.
[16]
宋萍, 郑成云. 白细胞介素-2协同白细胞介素-18活化自然杀伤细胞活性的作用[J]. 西安交通大学学报(医学版),2006,27(3):227-229.
[17]
Schönberg K, Rudolph J, Vonnahme M, et al. JAK inhibition impairs NK cell function in myeloproliferative neoplasms[J]. Cancer Res,2015,75(11):2187-2199.
[18]
Leng J, Zhang L, Yao H, et al. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma[J]. Chin Med J (Engl),2003,116(10):1475-1479.
[19]
田中秋, 邓立普. TNF-α, IL-6在全身炎症反应综合征表达的研究进展[J]. 蛇志,2008,20(4):275-278.
[20]
Campbell IK, Roberts LJ, Wicks IP. Molecular targets in immune-mediated diseases: the case of tumor necrosis factor and rheumatoid arthritis[J]. Immunol Cell Biol,2003,81(5):354-366.
[21]
Murdaca G, Spanò F, Contatore M, et al. Infection risk associated with anti-TNF-α agents: a review[J]. Expert Opin Drug Saf,2015,14(4):571-582.
[22]
韩玲娜, 王春雷, 李晓丽. TNF-α在神经病理性疼痛模型大鼠脑组织中的表达和作用[J]. 长治医学院学报,2009,23(4):247-249.
[23]
Chebli JMF, Gaburri PD, Chebli LA, et al. A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-alpha therapy[J]. Med Sci Monit,2014,26(20):487-498.
[24]
Yamaoka K. Benefit and risk of tofacitinib in the treatment of rheumatoid arthritis: a focus on herpes zoster[J]. Drug Saf,2016,39(9):823-840.
[25]
Wieseler-Frank J, Maier SF, Watkins LR. Central pro-inflammatory cytokines and pain enhancement[J]. Neurosignals,2005,14(4):166-174.
[26]
Zajkowska A, Garkowski A, Świerzbińska R, et al. Evaluation of chosen cytokine levels among patients with herpes zoster as ability to provide immune response[J]. PLoS one,2016,11(3):e0150301.
[1] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[2] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[3] 张伟, 孙浩亮. 心脏移植术后继发带状疱疹致Ogilvie综合征一例[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 239-241.
[4] 张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[5] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[6] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[7] 潘冬生, 梁国标. 颅脑创伤治疗的最新进展与未来趋势[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 193-197.
[8] 汤畅通, 王永楠, 王诗筌. 颅脑外伤后阵发性交感神经兴奋患者的药物治疗效果分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 233-237.
[9] 杨智钧, 谷佳, 丁聿贤, 张正奎, 于如同. 脑胶质瘤患者血清炎性因子水平与病理分级及预后的相关性[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 238-242.
[10] 吴天宇, 刘子璇, 杨浦鑫, 贾思明, 丁凯, 程晓东, 李泳龙, 陈伟, 吕红芝, 张奇. 腰椎间盘突出症保守治疗进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 379-384.
[11] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[12] 刘涛, 谢海波, 张雪竹. 针刺治疗节段性带状疱疹肌麻痹案[J/OL]. 中华针灸电子杂志, 2024, 13(04): 169-170.
[13] 陈秋怡, 林熙, 刘珍银. 淋巴管畸形分子机制的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 374-379.
[14] 张成惠, 闫中瑞, 盛志强, 袁嫣然. 脑肌酸缺乏症诊断与治疗研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 270-275.
[15] 胡瑞芳, 樊丽娟. 食管鳞状上皮内瘤变诊断的生物标志物研究进展及其非内镜治疗现状[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 281-286.
阅读次数
全文


摘要